美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

OPUS GENETICS INC

4.05

-0.0700-1.70%

盘后：4.130.0800+1.98%19:30 EDT

成交量：105.27万

成交额：443.35万

市值：3.37亿

市盈率：-3.13

高：4.33

开：4.16

低：4.02

收：4.12

52周最高：5.81

52周最低：1.12

股本：8,319.58万

流通股本：6,520.98万

量比：1.33

换手率：1.61%

股息：- -

股息率：- -

每股收益(TTM):-1.2925

每股收益(LYR):-0.8000

净资产收益率：-4796.52%

总资产收益率：-48.06%

市净率：-25.95

市盈率(LYR):-5.06

数据加载中...

总览公司新闻资讯公告

Opus Genetics 完成 LCA5 相关遗传性视网膜疾病候选药物 Opgx-Lca5 注册性 III 期试验患者入组

Opus Genetics宣布与美国食品药品监督管理局就Opgx-lca5治疗Lca5相关遗传性视网膜疾病的III期注册试验设计达成一致

Opus Genetics提交SEC文件：现有股东申请转售最多268万股普通股

Opus Genetics宣布FDA接受Opgx-Lca5纳入罕见病证据原则计划

奥伯兰资本承诺以每股4.48美元价格向Opus Genetics Inc注资500万美元

Opus Genetics Inc：奥伯兰资本可选择将最多10%票据转换为公司股票，每股作价6.72美元

Opus Genetics Inc获得最高1.55亿美元非稀释性融资首期注资3500万美元

Opus Genetics Inc向SEC提交文件注册740万股普通股供股东转售

Opus Genetics在黄斑学会年会公布Opgx-Best1基因疗法1/2期研究初步临床数据

Opus Genetics宣布FDA受理0.75%酚妥拉明滴眼液补充新药申请用于治疗老花眼

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/IRD/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IRD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IRD\",,,,,undefined,":{"symbol":"IRD","market":"US","secType":"STK","nameCN":"OPUS GENETICS INC","latestPrice":4.05,"timestamp":1787342400000,"preClose":4.12,"halted":0,"volume":1052694,"hourTrading":{"tag":"盘后","latestPrice":4.13,"preClose":4.05,"latestTime":"19:30 EDT","volume":9444,"amount":39917.4579,"timestamp":1787355004622,"change":0.08,"changeRate":0.019753,"amplitude":0.061728},"delay":0,"changeRate":-0.01699029126213599,"floatShares":65209799,"shares":83195823,"eps":-1.292468,"marketStatus":"未开盘","change":-0.07,"latestTime":"08-21 16:00:00 EDT","open":4.16,"high":4.33,"low":4.02,"amount":4433516.576154,"amplitude":0.075243,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.292468,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":0,"adr":0,"listingDate":1100235600000,"exchange":"NASDAQ","adjPreClose":4.12,"preHourTrading":{"tag":"盘前","latestPrice":4.15,"preClose":4.12,"latestTime":"09:28 EDT","volume":1230,"amount":5098.738188,"timestamp":1787318918091,"change":0.03,"changeRate":0.007282,"amplitude":0.038835},"postHourTrading":{"tag":"盘后","latestPrice":4.13,"preClose":4.05,"latestTime":"19:30 EDT","volume":9444,"amount":39917.4579,"timestamp":1787355004622,"change":0.08,"changeRate":0.019753,"amplitude":0.061728},"volumeRatio":1.3260679461087272,"impliedVol":2.8398,"impliedVolPercentile":0.852},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IRD\",,,,,undefined,":{"symbol":"IRD","floatShares":65209799,"roa":"-48.06%","roe":"-4796.52%","lyrEps":-0.8,"volumeRatio":1.3260679461087272,"shares":83195823,"dividePrice":0,"high":4.33,"amplitude":0.075243,"preClose":4.12,"low":4.02,"week52Low":1.124,"pbRate":"-25.95","psRate":"34.19","week52High":5.81,"institutionHeld":0,"latestPrice":4.05,"eps":-1.292468,"divideRate":0,"volume":1052694,"delay":0,"ttmEps":-1.292468,"open":4.16,"prevYearClose":2.01,"prevWeekClose":3.61,"prevMonthClose":3.71,"prevQuarterClose":4.11,"fiveDayClose":3.61,"twentyDayClose":3.08,"sixtyDayClose":4.14},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IRD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"IRD","fiscalQuarterEnding":"2026/06","expectedEps":-0.15,"name":null,"time":"盘前","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":-0.14},{"market":"US","date":"2026-05-12","symbol":"IRD","fiscalQuarterEnding":"2026/03","expectedEps":-0.16,"name":null,"time":"盘前","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"pre","actualEps":-0.75},{"market":"US","date":"2026-03-10","symbol":"IRD","fiscalQuarterEnding":"2025/12","expectedEps":-0.11,"name":null,"time":"盘前","type":"earning","dateTimestamp":1773115200000,"reportTimeType":"pre","actualEps":-0.14},{"market":"US","date":"2025-11-12","symbol":"IRD","fiscalQuarterEnding":"2025/09","expectedEps":-0.14,"name":null,"time":"盘前","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.12},{"market":"US","date":"2025-08-13","symbol":"IRD","fiscalQuarterEnding":"2025/06","expectedEps":-0.25,"name":null,"time":"盘后","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IRD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IRD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2632,"buy":0.7368,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7368,"analysts":19,"updateTime":1785384000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IRD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IRD","date":"2026-08-21","current":-3.13354,"percent":0.152655,"low":-8.249622,"twenty":-2.973207,"median":-1.951541,"eighty":-1.129716,"high":-0.560128,"avg":-2.373556,"sd":1.802154,"marketCap":342766790},"quantilePoints":[{"date":"2024-10-31","current":-2.785848,"twenty":-2.857166,"median":-2.64666,"eighty":-2.37374,"marketCap":39294383},{"date":"2024-11-08","current":-2.429259,"twenty":-2.692243,"median":-2.607554,"eighty":-2.476187,"marketCap":34264702},{"date":"2024-11-15","current":-1.225421,"twenty":-2.616468,"median":-2.568551,"eighty":-2.326813,"marketCap":33321637},{"date":"2024-11-22","current":-1.142487,"twenty":-2.607554,"median":-2.49612,"eighty":-1.192247,"marketCap":31066518},{"date":"2024-11-29","current":-1.288651,"twenty":-2.607554,"median":-2.173143,"eighty":-1.193702,"marketCap":35040987},{"date":"2024-12-06","current":-1.323479,"twenty":-2.603096,"median":-1.364112,"eighty":-1.225421,"marketCap":35988040},{"date":"2024-12-13","current":-1.288651,"twenty":-2.574123,"median":-1.335088,"eighty":-1.234669,"marketCap":35040987},{"date":"2024-12-20","current":-1.14597,"twenty":-2.527405,"median":-1.303163,"eighty":-1.16559,"marketCap":31161223},{"date":"2024-12-27","current":-1.253822,"twenty":-2.505202,"median":-1.288651,"eighty":-1.163268,"marketCap":34093933},{"date":"2025-01-03","current":-1.462793,"twenty":-2.49612,"median":-1.294455,"eighty":-1.172556,"marketCap":39776255},{"date":"2025-01-10","current":-1.683372,"twenty":-2.442631,"median":-1.320577,"eighty":-1.181843,"marketCap":45774262},{"date":"2025-01-17","current":-1.346698,"twenty":-2.224366,"median":-1.346698,"eighty":-1.20274,"marketCap":36619410},{"date":"2025-01-24","current":-1.335088,"twenty":-1.87928,"median":-1.335088,"eighty":-1.207384,"marketCap":36303725},{"date":"2025-01-31","current":-1.288651,"twenty":-1.676407,"median":-1.329284,"eighty":-1.218206,"marketCap":35040987},{"date":"2025-02-07","current":-1.416355,"twenty":-1.657832,"median":-1.323479,"eighty":-1.225421,"marketCap":38513517},{"date":"2025-02-14","current":-1.335088,"twenty":-1.648544,"median":-1.323479,"eighty":-1.239294,"marketCap":36303725},{"date":"2025-02-21","current":-1.288651,"twenty":-1.616038,"median":-1.323479,"eighty":-1.250654,"marketCap":35040987},{"date":"2025-02-28","current":-1.207384,"twenty":-1.525484,"median":-1.317674,"eighty":-1.232138,"marketCap":32831195},{"date":"2025-03-07","current":-1.160946,"twenty":-1.444218,"median":-1.31187,"eighty":-1.207384,"marketCap":31568457},{"date":"2025-03-14","current":-1.07968,"twenty":-1.411711,"median":-1.30026,"eighty":-1.1772,"marketCap":29358665},{"date":"2025-03-21","current":-1.335088,"twenty":-1.404745,"median":-1.30026,"eighty":-1.16559,"marketCap":36303725},{"date":"2025-03-28","current":-1.637559,"twenty":-1.525484,"median":-1.31187,"eighty":-1.1772,"marketCap":44528506},{"date":"2025-04-04","current":-0.76585,"twenty":-1.525484,"median":-1.306065,"eighty":-1.160946,"marketCap":44060874},{"date":"2025-04-11","current":-0.564318,"twenty":-1.462793,"median":-1.288651,"eighty":-1.14388,"marketCap":32466352},{"date":"2025-04-17","current":-0.581158,"twenty":-1.453505,"median":-1.288651,"eighty":-1.129154,"marketCap":33435158},{"date":"2025-04-25","current":-0.632466,"twenty":-1.414033,"median":-1.288651,"eighty":-1.081468,"marketCap":36387058},{"date":"2025-05-02","current":-0.741567,"twenty":-1.404745,"median":-1.288651,"eighty":-1.054291,"marketCap":42663825},{"date":"2025-05-09","current":-0.787263,"twenty":-1.404745,"median":-1.277041,"eighty":-0.791089,"marketCap":45292790},{"date":"2025-05-16","current":-0.737114,"twenty":-1.402423,"median":-1.253822,"eighty":-0.755291,"marketCap":43209631},{"date":"2025-05-23","current":-0.783669,"twenty":-1.393136,"median":-1.253822,"eighty":-0.759832,"marketCap":45938661},{"date":"2025-05-30","current":-0.771642,"twenty":-1.393136,"median":-1.251182,"eighty":-0.76585,"marketCap":45233661},{"date":"2025-06-06","current":-1.017762,"twenty":-1.393136,"median":-1.225421,"eighty":-0.767335,"marketCap":59661197},{"date":"2025-06-13","current":-1.009213,"twenty":-1.381526,"median":-1.207384,"eighty":-0.771254,"marketCap":59160042},{"date":"2025-06-20","current":-0.947842,"twenty":-1.372239,"median":-1.207384,"eighty":-0.771564,"marketCap":55562472},{"date":"2025-06-27","current":-1.038117,"twenty":-1.360629,"median":-1.184165,"eighty":-0.771642,"marketCap":60854420},{"date":"2025-07-03","current":-1.017762,"twenty":-1.358307,"median":-1.160946,"eighty":-0.77653,"marketCap":59661197},{"date":"2025-07-11","current":-1.139893,"twenty":-1.351342,"median":-1.160017,"eighty":-0.782117,"marketCap":66820540},{"date":"2025-07-18","current":-1.185692,"twenty":-1.346698,"median":-1.152239,"eighty":-0.783669,"marketCap":69505294},{"date":"2025-07-25","current":-1.231492,"twenty":-1.339732,"median":-1.160017,"eighty":-0.783669,"marketCap":72190048},{"date":"2025-08-01","current":-1.129716,"twenty":-1.335088,"median":-1.160248,"eighty":-0.785825,"marketCap":66223928},{"date":"2025-08-08","current":-1.10936,"twenty":-1.335088,"median":-1.151155,"eighty":-0.789762,"marketCap":65030704},{"date":"2025-08-15","current":-1.213067,"twenty":-1.335088,"median":-1.150071,"eighty":-0.791428,"marketCap":70691504},{"date":"2025-08-22","current":-1.177087,"twenty":-1.335088,"median":-1.151155,"eighty":-0.791428,"marketCap":68594722},{"date":"2025-08-29","current":-1.287434,"twenty":-1.335088,"median":-1.160248,"eighty":-0.791428,"marketCap":75025207},{"date":"2025-09-05","current":-1.384803,"twenty":-1.335088,"median":-1.160946,"eighty":-0.797415,"marketCap":80699383},{"date":"2025-09-12","current":-1.525447,"twenty":-1.342054,"median":-1.174821,"eighty":-0.822134,"marketCap":88895414},{"date":"2025-09-19","current":-1.611997,"twenty":-1.365273,"median":-1.182227,"eighty":-0.876364,"marketCap":93939125},{"date":"2025-09-26","current":-1.860829,"twenty":-1.384803,"median":-1.184928,"eighty":-0.929339,"marketCap":108439795},{"date":"2025-10-03","current":-1.947379,"twenty":-1.400101,"median":-1.195775,"eighty":-0.939944,"marketCap":113483507},{"date":"2025-10-10","current":-2.152936,"twenty":-1.42988,"median":-1.207384,"eighty":-0.94314,"marketCap":125462322},{"date":"2025-10-17","current":-2.174573,"twenty":-1.477844,"median":-1.207384,"eighty":-0.951343,"marketCap":126723249},{"date":"2025-10-24","current":-2.163754,"twenty":-1.521119,"median":-1.217191,"eighty":-0.957164,"marketCap":126092786},{"date":"2025-10-31","current":-2.131298,"twenty":-1.627334,"median":-1.225421,"eighty":-0.958345,"marketCap":124201394},{"date":"2025-11-07","current":-2.196211,"twenty":-1.661499,"median":-1.23256,"eighty":-0.960734,"marketCap":127984177},{"date":"2025-11-14","current":-2.001473,"twenty":-1.74585,"median":-1.242213,"eighty":-0.964942,"marketCap":116635827},{"date":"2025-11-21","current":-1.951541,"twenty":-1.828372,"median":-1.253822,"eighty":-0.975077,"marketCap":133100921},{"date":"2025-11-28","current":-2.153773,"twenty":-1.878321,"median":-1.253822,"eighty":-0.98727,"marketCap":146893763},{"date":"2025-12-05","current":-2.254889,"twenty":-1.925381,"median":-1.265432,"eighty":-0.988735,"marketCap":153790183},{"date":"2025-12-12","current":-2.467233,"twenty":-1.950709,"median":-1.277041,"eighty":-0.996674,"marketCap":168272667},{"date":"2025-12-19","current":-2.002099,"twenty":-2.002099,"median":-1.288651,"eighty":-1.007767,"marketCap":136549131},{"date":"2025-12-26","current":-2.062768,"twenty":-2.022322,"median":-1.288651,"eighty":-1.0085,"marketCap":140686984},{"date":"2026-01-02","current":-2.032433,"twenty":-2.02248,"median":-1.288651,"eighty":-1.00907,"marketCap":138618058},{"date":"2026-01-09","current":-2.022322,"twenty":-2.035652,"median":-1.288651,"eighty":-1.009619,"marketCap":137928416},{"date":"2026-01-16","current":-2.103215,"twenty":-2.062768,"median":-1.30026,"eighty":-1.016154,"marketCap":143445552},{"date":"2026-01-23","current":-2.527902,"twenty":-2.079519,"median":-1.303662,"eighty":-1.017762,"marketCap":172410520},{"date":"2026-01-30","current":-2.527902,"twenty":-2.105793,"median":-1.31187,"eighty":-1.017762,"marketCap":172410520},{"date":"2026-02-06","current":-2.608795,"twenty":-2.126582,"median":-1.317674,"eighty":-1.019861,"marketCap":177927656},{"date":"2026-02-13","current":-3.427836,"twenty":-2.136977,"median":-1.323479,"eighty":-1.031375,"marketCap":233788665},{"date":"2026-02-20","current":-3.609844,"twenty":-2.149226,"median":-1.323479,"eighty":-1.038117,"marketCap":246202222},{"date":"2026-02-27","current":-3.630068,"twenty":-2.153773,"median":-1.330709,"eighty":-1.044184,"marketCap":247581506},{"date":"2026-03-06","current":-4.823238,"twenty":-2.163754,"median":-1.335088,"eighty":-1.055298,"marketCap":328959272},{"date":"2026-03-13","current":-6.821589,"twenty":-2.163832,"median":-1.335088,"eighty":-1.05838,"marketCap":338289413},{"date":"2026-03-20","current":-6.571003,"twenty":-2.174573,"median":-1.340893,"eighty":-1.062543,"marketCap":325862626},{"date":"2026-03-27","current":-6.48492,"twenty":-2.196211,"median":-1.358307,"eighty":-1.072721,"marketCap":321593683},{"date":"2026-04-02","current":-6.728822,"twenty":-2.279157,"median":-1.369917,"eighty":-1.078827,"marketCap":333689021},{"date":"2026-04-10","current":-7.890943,"twenty":-2.31549,"median":-1.383164,"eighty":-1.078974,"marketCap":391319747},{"date":"2026-04-17","current":-8.249622,"twenty":-2.347317,"median":-1.393136,"eighty":-1.079587,"marketCap":409107008},{"date":"2026-04-24","current":-7.474875,"twenty":-2.424764,"median":-1.39894,"eighty":-1.079843,"marketCap":370686524},{"date":"2026-05-01","current":-7.357517,"twenty":-2.49456,"median":-1.404745,"eighty":-1.081468,"marketCap":364866631},{"date":"2026-05-08","current":-7.717474,"twenty":-2.527902,"median":-1.450845,"eighty":-1.086096,"marketCap":382717249},{"date":"2026-05-15","current":-3.318654,"twenty":-2.605325,"median":-1.471353,"eighty":-1.089005,"marketCap":354870285},{"date":"2026-05-22","current":-2.864592,"twenty":-2.625631,"median":-1.50381,"eighty":-1.089833,"marketCap":306316604},{"date":"2026-05-29","current":-2.804496,"twenty":-2.764432,"median":-1.520037,"eighty":-1.093147,"marketCap":299890382},{"date":"2026-06-05","current":-3.098301,"twenty":-2.804496,"median":-1.567278,"eighty":-1.099183,"marketCap":331307470},{"date":"2026-06-12","current":-2.976252,"twenty":-2.841362,"median":-1.641006,"eighty":-1.10936,"marketCap":318256557},{"date":"2026-06-18","current":-3.09043,"twenty":-2.862186,"median":-1.648544,"eighty":-1.10936,"marketCap":330465888},{"date":"2026-06-26","current":-2.831626,"twenty":-2.921273,"median":-1.671763,"eighty":-1.117502,"marketCap":302791405},{"date":"2026-07-02","current":-3.181773,"twenty":-2.964753,"median":-1.703207,"eighty":-1.119538,"marketCap":340233353},{"date":"2026-07-10","current":-3.103979,"twenty":-3.005472,"median":-1.779688,"eighty":-1.123486,"marketCap":331914656},{"date":"2026-07-17","current":-2.5326,"twenty":-2.998741,"median":-1.85001,"eighty":-1.127372,"marketCap":270815938},{"date":"2026-07-24","current":-2.254631,"twenty":-2.977774,"median":-1.874663,"eighty":-1.129113,"marketCap":241092238},{"date":"2026-07-31","current":-2.964995,"twenty":-2.973207,"median":-1.900983,"eighty":-1.129716,"marketCap":317052806},{"date":"2026-08-07","current":-2.854241,"twenty":-2.967182,"median":-1.931317,"eighty":-1.129716,"marketCap":307144906},{"date":"2026-08-14","current":-2.87602,"twenty":-2.967182,"median":-1.947379,"eighty":-1.129716,"marketCap":309488461},{"date":"2026-08-21","current":-3.185269,"twenty":-2.973207,"median":-1.951541,"eighty":-1.129716,"marketCap":342766790}],"updateTime":1787530069520},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IRD\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1133103691","title":"Opus Genetics 完成 LCA5 相关遗传性视网膜疾病候选药物 Opgx-Lca5 注册性 III 期试验患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1133103691","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133103691?lang=zh_cn&edition=fundamental","pubTime":"2026-08-03 19:02","pubTimestamp":1785754942,"startTime":"0","endTime":"0","summary":"Opus Genetics 宣布，为其针对 LCA5 相关遗传性视网膜疾病研发的候选药物 Opgx-Lca5，已成功完成注册性 III 期临床试验的患者入组工作。这一里程碑，标志着该药物研发进程迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IRD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198935656","title":"Opus Genetics宣布与美国食品药品监督管理局就Opgx-lca5治疗Lca5相关遗传性视网膜疾病的III期注册试验设计达成一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1198935656","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198935656?lang=zh_cn&edition=fundamental","pubTime":"2026-07-06 19:03","pubTimestamp":1783335801,"startTime":"0","endTime":"0","summary":"Opus Genetics公司宣布，已与美国食品药品监督管理局就Opgx-lca5针对Lca5相关遗传性视网膜疾病的III期注册试验设计达成共识。这一关键进展标志着该候选疗法的临床开发路径进一步明确，为其后续的注册申请奠定了重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","IRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106560473","title":"Opus Genetics提交SEC文件：现有股东申请转售最多268万股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1106560473","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106560473?lang=zh_cn&edition=fundamental","pubTime":"2026-06-06 04:34","pubTimestamp":1780691651,"startTime":"0","endTime":"0","summary":"Opus Genetics已向美国证券交易委员会提交文件，申请由现有股东转售最多268万股公司普通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IRD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128138132","title":"Opus Genetics宣布FDA接受Opgx-Lca5纳入罕见病证据原则计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1128138132","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128138132?lang=zh_cn&edition=fundamental","pubTime":"2026-05-05 04:32","pubTimestamp":1777926769,"startTime":"0","endTime":"0","summary":"Opus Genetics公司近日宣布，其基因治疗候选药物Opgx-Lca5已获得美国食品药品监督管理局批准，正式纳入罕见病证据原则计划。这一重要进展标志着该公司在针对罕见遗传性视网膜疾病治疗领域的研发迈出关键一步。Opgx-Lca5作为针对LCA5基因突变相关莱伯先天性黑蒙症的治疗方案，此次入选将进一步推动该药物的临床开发进程。对于Opus Genetics而言，此次FDA的认可不仅验证了其科学平台的技术潜力，也为后续与其他监管机构的沟通奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRD","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130712669","title":"奥伯兰资本承诺以每股4.48美元价格向Opus Genetics Inc注资500万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1130712669","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130712669?lang=zh_cn&edition=fundamental","pubTime":"2026-04-06 19:06","pubTimestamp":1775473583,"startTime":"0","endTime":"0","summary":"奥伯兰资本已正式承诺，将以每股4.48美元的价格对Opus Genetics Inc进行500万美元的股权投资。这项投资将直接用于认购该公司的股票。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","IRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168121332","title":"Opus Genetics Inc：奥伯兰资本可选择将最多10%票据转换为公司股票，每股作价6.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1168121332","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168121332?lang=zh_cn&edition=fundamental","pubTime":"2026-04-06 19:06","pubTimestamp":1775473582,"startTime":"0","endTime":"0","summary":"生物技术公司Opus Genetics Inc宣布，其发行的票据中最多10%的部分，可由投资机构奥伯兰资本（Oberland Capital）自主选择转换为公司普通股，转换价格设定为每股6.72美元。此项条款为奥伯兰资本提供了将债权转换为股权的灵活性，潜在增加了其对公司的持股比例。转换价格的设定也反映了市场对公司股权价值的当前评估。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRD","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169713083","title":"Opus Genetics Inc获得最高1.55亿美元非稀释性融资 首期注资3500万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1169713083","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169713083?lang=zh_cn&edition=fundamental","pubTime":"2026-04-06 19:04","pubTimestamp":1775473459,"startTime":"0","endTime":"0","summary":"生物技术公司Opus Genetics Inc近日宣布成功设立新的票据融资机制，通过该渠道可获得总额高达1.55亿美元的非稀释性资金支持。值得关注的是，该融资方案首期即提供3500万美元的即时资金注入。\n此次融资安排采用票据融资模式，既保障了公司研发资金的持续供给，又有效避免了股权稀释对现有股东权益的影响。非稀释性融资的特性使公司在保持资本结构稳定的同时，能够灵活调配资源推进基因治疗领域的创新研究。\n该融资机制将分阶段释放资金，后续款项的拨付将与公司达成特定研发里程碑挂钩。这种结构化设计既体现了投资方对Opus Genetics技术实力的认可，也为公司未来的科研进展提供了持续动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRD","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170710516","title":"Opus Genetics Inc向SEC提交文件 注册740万股普通股供股东转售","url":"https://stock-news.laohu8.com/highlight/detail?id=1170710516","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170710516?lang=zh_cn&edition=fundamental","pubTime":"2026-03-14 05:05","pubTimestamp":1773435900,"startTime":"0","endTime":"0","summary":"生物技术公司Opus Genetics Inc近日向美国证券交易委员会提交文件，正式注册740万股普通股用于二级市场转售。此次注册的股票全部由现有股东提供，旨在为持股人创造流动性机会。根据公开披露信息，这批股票将根据市场情况择机通过公开市场交易进行出售。作为一家专注于眼科基因治疗研发的企业，Opus Genetics Inc此次股权变动备受市场关注。投资者需密切关注后续持股变动公告，以准确把握股东结构变化趋势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRD","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146253007","title":"Opus Genetics在黄斑学会年会公布Opgx-Best1基因疗法1/2期研究初步临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1146253007","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146253007?lang=zh_cn&edition=fundamental","pubTime":"2026-02-27 23:13","pubTimestamp":1772205224,"startTime":"0","endTime":"0","summary":"OPUS GENETICS INC于黄斑学会年度会议上首次披露了其Opgx-Best1基因治疗项目的1/2期临床试验初步结果。该研究旨在评估针对遗传性视网膜疾病的新型基因疗法的安全性与有效性。此次数据公布标志着公司在眼科基因治疗领域取得重要进展，为后续临床开发提供了关键依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRD","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199651408","title":"Opus Genetics宣布FDA受理0.75%酚妥拉明滴眼液补充新药申请 用于治疗老花眼","url":"https://stock-news.laohu8.com/highlight/detail?id=1199651408","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199651408?lang=zh_cn&edition=fundamental","pubTime":"2026-02-25 19:59","pubTimestamp":1772020779,"startTime":"0","endTime":"0","summary":"Opus Genetics公司近日宣布，美国食品药品监督管理局（FDA）已正式受理其针对0.75%酚妥拉明滴眼液所提交的补充新药申请（sNDA）。该药物旨在用于治疗老花眼，标志着公司在眼科治疗领域取得重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IRD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}]}}